CHRONOPHARMACOLOGY TIME DEPENDENT PHARMACOTHERAPY (HB 2025). Questo articolo non è disponibile.
Lingua: inglese
Editore: TAYLOR & FRANCIS NP EXCLUSIVE(CBS), 2025
- Rilegato
- Nuovo

Da: UK BOOKS STORE, London, London, Regno UnitoUK BOOKS STORE
Venditore AbeBooks dal 11 marzo 2024
Condizione: Nuovo
EUR 246,66
Descrizione dell’articolo da parte del venditore
Brand New ! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Codice articolo Cvs 9781041067191
- Titolo
- CHRONOPHARMACOLOGY TIME DEPENDENT PHARMACOTHERAPY (HB 2025)
- Autore
- SIDDIQUI M A
- Editore
- TAYLOR & FRANCIS NP EXCLUSIVE(CBS)
- Anno di pubblicazione
- 2025
- Condizione
- New
- Rilegatura
- Rilegato
- Lingua
- inglese
- ISBN 10
- 1041067194
- ISBN 13
- 9781041067191
- Edizione
- Edizione Internazionale
Chronopharmacology: Time-Dependent Pharmacotherapy explores the cutting-edge science of tailoring drug administration to the body's natural biological rhythms, known as circadian rhythms. This comprehensive book provides healthcare professionals and researchers a deep understanding of how the timing of drug administration can impact therapeutic efficacy, safety, and patient outcomes. By integrating knowledge from pharmacology, chronobiology, and clinical medicine, the book offers both theoretical insights and practical guidelines for applying chronopharmacology in the treatment of diseases like cardiovascular disorders, cancer, and sleep-related conditions. Through case studies and the latest research on circadian-based drug delivery systems, this text is an invaluable resource for clinicians aiming to optimize patient care and researchers exploring new frontiers in personalized medicine.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
Mohd Aftab Siddiqui is an Associate Professor at Integral University's Faculty of Pharmacy, Lucknow, India. He obtained a PhD in Pharmacology in 2020, following distinguished M Pharm (2015) and B Pharm (2013) degrees. He has an excellent academic record and has significant teaching and research experience. His work focuses on natural products, drug discovery, and pharmacological interventions. Dr. Siddiqui has authored articles, contributed to book chapters, edited books, and served in administrative roles and professional societies. Honored with awards like the "Young Scientist Award," his ongoing research and publications advance pharmacological sciences.
Afreen Usmani is an Associate Professor and Vice Principal at MESCO Institute of Pharmacy, Amroha, India. She specializes in nanomedicine and targeted drug delivery. A PhD graduate in Pharmacology from Integral University, India, she has authored over 32 research articles, numerous book chapters, and more than 12 academic books widely recognized in pharmaceutical education. Holding multiple patents, she contributes to pharmacology, toxicology, nanotechnology, and drug development. Dr. Usmani actively participates in conferences, serves on journal editorial boards, and is a lifetime member of the Society for Progressive Letters, continuing to inspire and advance pharmaceutical sciences.
Mohd Nazam Ansari is a Professor in Pharmacology and Toxicology at PSAU, Saudi Arabia. He obtained a PhD in Pharmacology in 2008 from Hamdard University, India. With over 150 publications, 13 research projects, and extensive global conference participation, he is a recognized expert in his field. Dr. Ansari is a member of prominent pharmacological societies and serves on editorial boards of reputed journals.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.